Patients are advised to immediately contact their healthcare professional and seek care if they take PPIs and develop diarrhea that does not improve.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Providers are advised to consider a diagnosis of CDAD for PPI users with diarrhea that does not improve.
FDA said it is working with manufacturers to include information about the increased risk of CDAD with use of PPIs in the drug labels. FDA also said it is reviewing the risk of CDAD in users of histamine H2 receptor blockers.
Related Articles on Clostridium Difficile:
Study: Fecal Microbiota Transplantation Effective Treatment of Recurrent Clostridium difficile
Patients Aged 85 And Older at Highest Risk of C. Difficile
C. Difficile Infections Could Lengthen Hospital Stays by 6 Days
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
